 As TPC2 plays a vital role in this specific mechanism of Parkinson’s disease development, it may potentially be a therapeutic target.The Ebolavirus takes advantage of host cell endocytotic membrane trafficking, leaving TPCs as a potential drug target.Ebolavirus enter cells through micropinocytosis with endosomal vesicles.